Invention Grant
- Patent Title: Methods for affecting body composition using amylin agonists
- Patent Title (中): 使用胰岛淀粉样多肽激动剂影响身体组成的方法
-
Application No.: US13256779Application Date: 2010-03-17
-
Publication No.: US08748375B2Publication Date: 2014-06-10
- Inventor: Christine M. Mack , Jonathan David Roth
- Applicant: Christine M. Mack , Jonathan David Roth
- Applicant Address: US CA San Diego US DE Wilmington
- Assignee: Amylin Pharmaceuticals, LLC,AstraZeneca Pharmaceuticals LP
- Current Assignee: Amylin Pharmaceuticals, LLC,AstraZeneca Pharmaceuticals LP
- Current Assignee Address: US CA San Diego US DE Wilmington
- Agency: Womble Carlyle Sandridge & Rice LLP
- Agent Mark J. Pino; Alireza Behrooz
- International Application: PCT/US2010/027599 WO 20100317
- International Announcement: WO2010/107874 WO 20100923
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K38/16
Abstract:
Methods for affecting body composition include the use of amylin agonists, such as pramlintide or davalintide. Total body weight may be reduced, maintained or even increased; however, the body fat is reduced or body fat gain is prevented, while lean body mass is maintained or increased.
Public/Granted literature
- US20120053118A1 METHODS FOR AFFECTING BODY COMPOSITION USING AMYLIN AGONISTS Public/Granted day:2012-03-01
Information query
IPC分类:
